Contents
- Small tumor size does not necessarily mean small risk
- High rate of interval tumors means vigilance is essential
Triple negative cancer of the breast patients given lumpectomy and appropriate additional treatment (typically, radiotherapy and chemotherapy) possess a greater chance of locoregional recurrence than other cancer of the breast subtypes. Locoregional recurrence is recurrence within the breast, chest wall, or lymph nodes. However, lumpectomy isn’t connected with elevated locoregional recurrence rates among triple negative patients when compared with mastectomy.
Receiving timely treatment methods are particularly important for triple negative cancer of the breast patients. One 2015 study reported that the delay in excess of 3 months in beginning adjuvant chemotherapy (after surgery to get rid of the tumor) was connected having a 53% greater chance of cancer of the breast-specific dying when compared with treatment which was began within thirty days. The comparable risk for those cancer of the breast types was 27%.
Rates of recent tumors within the other breast and distant recurrence throughout the first 5 years after diagnosis will also be greater in triple negative when compared with other cancer of the breast subtypes no matter kind of breast surgery.
Small tumor size does not necessarily mean small risk
While small tumor size and negative lymph node status typically are connected wth favorable cancer of the breast prognosis, this isn’t always the situation for triple negative tumors. Women with small (<1 cm), lymph node negative breast tumors are at higher risk of relapse if they have triple negative disease.
High rate of interval tumors means vigilance is essential
There’s some evidence that recurrences within the same breast or new tumors within the other breast frequently are self-detected instead of found included in regular follow-up screening of cancer of the breast survivors. One study discovered that more than one-third of these recurrences weren’t screen-detected (quite simply, these were typically symptomatic and detected through the women themselves). The authors figured that a current negative mammogram shouldn’t falsely reassure women with new breast signs and symptoms or changes since several second cancers are interval cancers (cancers found between screening visits). Triple negative cancer of the breast survivors ought to be especially vigilant throughout the first 5 years after diagnosis and produce any alterations in their breasts towards the attention of the oncologists or surgeons.
Below under Selected cancer of the breast studies are links to recent reports in regards to the prognosis of triple negative cancer of the breast when compared with other subtypes. The studies provide specific statistics concerning survival, which varies based on numerous factors. For any more complete listing of studies (including less recent reports), please click triple negative.
Food for Cancer Of The Breast triple negative cancer of the breast articles
Here are links to the many other articles concerning triple negative cancer of the breast.
Triple negative cancer of the breast
Cancer of the breast diet for triple negative patients and survivors
Latest research concerning triple negative cancer of the breast prognosis
Patterns of recurrence in triple negative cancer of the breast patients
Tumor characteristics influencing prognosis of triple negative cancer of the breast
Prognosis of African Americans and Latinas with triple negative cancer of the breast
Influence of Body mass index, metabolic syndrome and diabetes on triple negative cancer of the breast prognosis
Triple negative cancer of the breast prognosis based on age at diagnosis
Resourse: http://foodforbreastcancer.com/articles/
